학술논문
WCN23-0403 AN OPEN-LABEL, NON-RANDOMIZED EXTENSION STUDY TO EVALUATE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF LNP023 IN SUBJECTS WITH C3 GLOMERULOPATHY: INTERIM ANALYSIS OF PHASE 2 STUDY
Document Type
Abstract
Author
Source
In Kidney International Reports March 2023 8(3) Supplement:S270-S271
Subject
Language
ISSN
2468-0249